Literature DB >> 21143762

Outcomes of percutaneous zygapophysial and sacroiliac joint neurotomy in a community setting.

Geoffrey C Speldewinde1.   

Abstract

OBJECTIVE: To evaluate the analgesic, physical, and psychological outcomes of percutaneous radiofrequency neurotomy for persistent zygapophysial and sacroiliac joint pain in a community setting.
DESIGN: A prospective evaluation of 379 consecutive neurotomies in a single specialist practice over an extended period 2001-2010.
SETTING: A provincial community environment in Australia. PATIENTS: All patients who had positive responses to diagnostic blocks, performed according to the guidelines of the International Spine Intervention Society by three trained specialists, underwent percutaneous radiofrequency thermal neurotomies performed by the author.
INTERVENTIONS: Radiofrequency neurotomies to denervate the zygapophysial or sacroiliac joints according to the standards of the International Spine Intervention Society. OUTCOME MEASURES: Numerical Rating Scale for Pain, Functional Rating Index, 4-Activities of Daily Living Scale, General Health Questionnaire, Depression Anxiety Stress Scale, duration of pain relief, "whether they would do it again," and overall amount of pain relief.
RESULTS: Of 379 procedures, 272 (72%) were regarded as successful by the patients. Irrespective of region treated. The results were highly significant by t-test, and the effect size was large as determined by the Cohen's d. Adverse events were infrequent and relatively minor. Repetitions of the procedure were highly successful.
CONCLUSIONS: Neurotomy of the cervical, thoracic, lumbar, and sacroiliac joints were uniformly successful with 72% recipients obtaining an average of 86% reduction in pain for a period of 12 months. Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21143762     DOI: 10.1111/j.1526-4637.2010.01022.x

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  6 in total

Review 1.  Facet joint pain--advances in patient selection and treatment.

Authors:  Steven P Cohen; Julie H Y Huang; Chad Brummett
Journal:  Nat Rev Rheumatol       Date:  2012-11-20       Impact factor: 20.543

2.  Consensus practice guidelines on interventions for cervical spine (facet) joint pain from a multispecialty international working group.

Authors:  Robert W Hurley; Meredith C B Adams; Meredith Barad; Arun Bhaskar; Anuj Bhatia; Andrea Chadwick; Timothy R Deer; Jennifer Hah; W Michael Hooten; Narayan R Kissoon; David Wonhee Lee; Zachary Mccormick; Jee Youn Moon; Samer Narouze; David A Provenzano; Byron J Schneider; Maarten van Eerd; Jan Van Zundert; Mark S Wallace; Sara M Wilson; Zirong Zhao; Steven P Cohen
Journal:  Pain Med       Date:  2021-11-26       Impact factor: 3.750

3.  Consensus practice guidelines on interventions for cervical spine (facet) joint pain from a multispecialty international working group.

Authors:  Robert W Hurley; Meredith C B Adams; Meredith Barad; Arun Bhaskar; Anuj Bhatia; Andrea Chadwick; Timothy R Deer; Jennifer Hah; W Michael Hooten; Narayan R Kissoon; David Wonhee Lee; Zachary Mccormick; Jee Youn Moon; Samer Narouze; David A Provenzano; Byron J Schneider; Maarten van Eerd; Jan Van Zundert; Mark S Wallace; Sara M Wilson; Zirong Zhao; Steven P Cohen
Journal:  Reg Anesth Pain Med       Date:  2021-11-11       Impact factor: 6.288

Review 4.  A Review of the Clinical Utility of Therapeutic Facet Joint Injections in Whiplash Associated Cervical Spinal Pain.

Authors:  Kelechi Eseonu; Jaykar Panchmatia; David Pang; Bahram Fakouri
Journal:  Spine Surg Relat Res       Date:  2021-12-14

Review 5.  Sacroiliac joint pain after lumbar/lumbosacral fusion: current knowledge.

Authors:  Hiroyuki Yoshihara
Journal:  Eur Spine J       Date:  2012-05-13       Impact factor: 3.134

6.  Cryoneurolysis for the treatment of cervical facet joint syndrome: a technical note.

Authors:  Tilman Wolter; Barbara Kleinmann; Stefan Knoeller
Journal:  J Pain Res       Date:  2018-06-19       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.